$SPL 0.145 on pump news $52m MCRange (creation) trade on news of some description.
ST target in blue.
Ill be very surprised if this doesnt at least close HOD
350m SOI
US listing SPHRY
Holding from 145
−0.020AUD
−15.64 MAUD
2.94 MAUD
386.67 M
About STARPHARMA HOLDINGS LIMITED
Sector
CEO
Cheryl Maley
Headquarters
Abbotsford
Website
Employees (FY)
45
Founded
1997
ISIN
AU000000SPL0
FIGI
BBG000BW3K53
Starpharma Holdings Ltd. engages in the research and development of dendrimer products for pharmaceutical, life science and other applications. The firm's programs include: VivaGel portfolio, Drug delivery and Agrochemicals, which develops a number of products internally and others via commercial partnerships. Its product VivaGel, a gel-based formulation of a proprietary dendrimer and is under clinical development for the treatment and prevention of bacterial vaginosis and also as a vaginal microbicide to prevent the transmission of sexually transmitted infections including HIV and genital herpes. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
$SPL ASX - Starpharma Holdings might be a small playStarpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL's underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and
Speculative Stockpick #2SPL is a highly speculative stock (refer VectorVest Strategic Investment Matrix) with RV <1.0 and RS = 1.0.
We only consider this stock for very short term because of its explosive potential… A strong RT value.
The RT value is trending up since the confirmation of bullish abandoned baby which is
SPL.AX Starphrama poised for future gainsStarpharma is posting some nice technicals that may be indicative of another impulse move
See previous analysis on Starpharma
Vectorvest VS Technical AnalysisVectorvest VS technical analysis
Strategy | Entry Price
Midas Touch MA RT(40) crossover | $0.69
Midas Touch MA Stop (10 & 60 ) crossover | $0.74
DEW Crossover | $0.69
MACD Crossover
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SPL is 0.15 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange STARPHARMA HOLDINGS LIMITED stocks are traded under the ticker SPL.
STARPHARMA HOLDINGS LIMITED is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
STARPHARMA HOLDINGS LIMITED revenue for the last quarter amounts to 3.10 M AUD despite the estimated figure of 3.10 M AUD. In the next quarter revenue is expected to reach 9.00 M AUD.
Yes, you can track STARPHARMA HOLDINGS LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, SPL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STARPHARMA HOLDINGS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 45.00 employees. See our rating of the largest employees — is STARPHARMA HOLDINGS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STARPHARMA HOLDINGS LIMITED EBITDA is −15.27 M AUD, and current EBITDA margin is −798.91%. See more stats in STARPHARMA HOLDINGS LIMITED financial statements.